US Patent 11872266 Rapid-acting insulin compositions
Patent 11872266 was granted and assigned to Eli Lilly and Company on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+389 characters)
US Patent 11872266 Rapid-acting insulin compositions
Article
Patent abstract
The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chad D. Paavola0
Chi A. Nguyen0
Michael Patrick Akers0
Nanette Elizabeth Schulte0
Ranajoy Majumdar0
Virender Kumar Sarin0
Date of Patent
January 16, 2024
0Patent Application Number
174787470
Date Filed
September 17, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11872266 Rapid-acting insulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
